Interscalene Block With Liposomal Bupivacaine vs. Interscalene Block With Bupivacaine and Adjuvants
Clinical trial NCT03845894 · TERMINATED
Trial details
- NCT number
- NCT03845894
- Sponsor
- Wake Forest University Health Sciences
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-03
- Primary completion
- 2022-06-25
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.